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Long-term changes in pharyngeal airway dimensions following
activator-headgear and fixed appliance treatment
Abstract
The aim of this study was to evaluate changes in the pharyngeal airway in growing children and
adolescents and to compare these with a group of children who received activator-headgear Class II
treatment. The sample consisted of 64 children (32 males and 32 females), 32 had a combined
activator-headgear appliance for at least 9 months (study group) followed by fixed appliance therapy in
most patients, while the other half received only minor orthodontic treatment (control group). Lateral
cephalograms before treatment (T1, mean age 10.4 years), at the end of active treatment (T2, mean age
14.5 years), and at the long-term follow-up (T3, mean age 22.1 years) were traced and digitized. To
reveal the influence of somatic growth, body height measurements were also taken into consideration. A
two-sample t-test was applied in order to determine differences between the groups. At T1, the study
group had a smaller pharynx length (P = 0.030) and a greater ANB angle (P < 0.001) than the controls.
The pharyngeal area and the smallest distance between the tongue and the posterior pharyngeal wall also
tended to be smaller in the study group. During treatment (T1-T2), significant growth differences
between the two groups were present: the study group had a greater reduction in ANB (P < 0.001) and
showed a greater increase in pharyngeal area (P = 0.007), pharyngeal length (P < 0.001) and the smallest
distance between the tongue and the posterior pharyngeal wall (P = 0.038). At T2, the values for the
study group were similar to those of the control group and remained stable throughout the
post-treatment interval (T2-T3). Activator-headgear therapy has the potential to increase pharyngeal
airway dimensions, such as the smallest distance between the tongue and the posterior pharyngeal wall
or the pharyngeal area. Importantly, this increase seems to be maintained long term, up to 22 years on
average in the present study. This benefit may result in a reduced risk of developing long-term impaired
respiratory function.
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Summary 
 
The aim of this study was to evaluate changes in the pharyngeal airway in growing children and 
adolescents and to compare these with a group of children who received activator-headgear Class II 
treatment. The sample consisted of 64 children (32 males and 32 females), 32 had a combined 
activator-headgear appliance for at least 9 months (study group) followed by fixed appliance therapy 
in most patients, while the other half received only minor orthodontic treatment (control group). 
Lateral cephalograms before treatment (T1, mean age 10.4 years), at the end of active treatment (T2, 
mean age 14.5 years) and at the long-term follow-up (T3, mean age 22.1 years) were traced and 
digitized. To reveal the influence of somatic growth, body height measurements were also taken into 
consideration. A two-sample t-test was applied in order to determine differences between the 
groups. 
At T1 the study group had a smaller pharynx length (p=0.030) and a greater ANB angle (p<0.001) 
than the controls. The pharyngeal area and the smallest distance between the tongue and the 
posterior pharyngeal wall also tended to be smaller in the study group. During treatment (T1-T2) 
significant growth differences between the two groups were present: the study group had a greater 
reduction in ANB (p<0.001) and showed a greater increase in the pharyngeal area (p=0.007), 
pharyngeal length (p<0.001) and the smallest distance between the tongue and the posterior 
pharyngeal wall (p=0.038). At T2 the values of the study group were similar to those of the control 
group and remained stable throughout the post-treatment interval (T2-T3). Activator-headgear 
therapy has the potential to increase pharyngeal airway dimensions, such as the smallest distance 
between the tongue and the posterior pharyngeal wall or the pharyngeal area. Importantly, this 
increase seems to be maintained long-term, up to 22 years on average in the present study. This 
benefit may result in a reduced risk of developing long-term impaired respiratory function. 
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Introduction 
 
Obstructive sleep apnoea (OSA), a common and frequently undiagnosed medical disorder in 
adults (Young et al., 2002), is characterized by recurrent pharyngeal airway obstruction during sleep. 
Frequent episodes of hypoxia and awakenings disrupt continuous sleep and even mild OSA is 
associated with significant morbidity (Young et al., 2002). While OSA, or sleep disordered breathing, 
has been reported in adolescents and children (Guilleminault et al., 1976; Contencin et al., 2003), it is 
most common in middle aged adults (Young et al., 2002). The reasons for the greater incidence of 
this disorder in later life are due to obesity (Martin et al., 1997; Finkelstein et al., 2001; Young et al., 
2002), family background (Mathur and Douglas, 1995; Schwab et al., 2006) or natural physiological 
changes. It has been observed that the depth of the oropharyngeal airway decreases with age 
(Martin et al., 1997), and that the soft palate becomes longer and thicker (Johnston and Richardson, 
1999). Supine posture and physiological decrease of muscular tonus during sleep cause additional 
significant reductions of pharyngeal airway dimensions (Pae et al., 1994; Martin et al., 1997; Smith 
and Battagel, 2004). 
When the airway and associated structures were examined, both snorers and OSA subjects 
exhibited reduced anteroposterior dimensions, narrower airways, reduced oropharyngeal areas and 
larger tongues (Lowe et al., 1986a; Battagel and L'Estrange, 1996; Battagel et al., 2000). According to 
cephalometric studies, OSA patients seem to have shorter (Battagel et al., 2000) and more 
retrognathic mandibles and also an anteroposterior discrepancy between the maxilla and mandible 
(Lowe et al., 1995). Furthermore, it has been shown that there is a correlation between the minimum 
axial cross-sectional area of the oropharyngeal lumen and the oxygen saturation and quantity as well 
as duration of apnoea episodes (Avrahami and Englender, 1995). Previous reports (Launois et al., 
1993; Morrison et al., 1993), have emphasized the significance of the most constricted sites 
(retropalatal and retroglossal) of the upper airway in airflow dynamics. It is at such sites in the upper 
airway that critical narrowing is likely to occur, and therefore changes in the dimension of these sites 
are of particular importance (Ono et al., 2000). 
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Lateral cephalometry is an established tool in the investigation of the airway in OSA subjects and 
it has been employed for diagnostic purposes (Battagel et al., 2000; Kuhnel et al., 2005) and to 
monitor therapeutic response (Battagel et al., 1999). Reproducibility of airway dimensions on lateral 
cephalograms has been studied and found to be highly accurate (Malkoc et al., 2005). However, a 
number of limitations of lateral cephalometry have been discussed (Lowe et al., 1986b; Finkelstein et 
al., 2001), particularly inadequate description of the airway on a two-dimensional radiograph. 
Although nasal continuous positive airway pressure (CPAP) remains the non-invasive treatment of 
choice for severe OSA in adults, various intraoral mandibular advancement devices (MAD) are 
successfully used for treating mild to moderate OSA and snoring (Bloch et al., 2000; Marklund et al., 
2004). MAD's are thought to prevent upper airway collapse during sleep by holding the mandible in a 
forward position, thereby increasing genioglossus muscle activity and pharyngeal airway space 
(Adachi et al., 1993). It has been shown that the percentage of alterations in airway dimensions 
matched or exceeded the amount of mandibular advancement and that the minimum distances 
behind the soft palate and tongue improved while wearing these devices (Battagel et al., 1999). 
In growing children, similar oral appliances such as MAD's (for example activators) have been 
used for many decades to modify mandibular growth in skeletal Class II patients. In contrast to 
mandibular advancement devices used in adults, activators are considered to enhance skeletal 
growth of the mandible. Even though there are numerous studies to examine skeletal changes with 
functional-orthopaedic treatment in Class II children, there appears to be only one study (Ozbek et 
al., 1998) that has investigated pharyngeal airway dimension changes caused by these devices. 
However, that investigation had only a short observation time (1.5 years in the treatment group) and 
was somewhat biased since only good responders were considered for the treatment group (treated 
patients who did not achieve a Class I occlusion and sufficient overjet reduction were excluded) and 
because two different types of activators were used as one group (with and without headgear). 
The aims of this long-term study were to examine physiological changes in the pharyngeal airway 
size in healthy children and to compare them with a group of children who received activator-
headgear treatment to determine possible treatment effects. 
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Materials and methods 
 
Subjects 
 
The 64 subjects (32 males and 32 females) participating in this study were randomly selected from 
the archives at the Clinic for Orthodontics and Pediatric Dentistry at the University of Zurich. 
Preconditions for the selection of patients of both groups were: no extractions or space closure of 
congenitally missing teeth, no skeletal Class III malocclusion, no extreme skeletal deep or open bite, 
no orthognathic surgery, no rapid maxillary expansion, remaining growth (by means of hand wrist 
radiograph), at least three lateral cephalograms of good quality: before treatment (T1), at the end of 
active treatment (T2) and at the end of the long-term follow-up (T3) with the patient being at least 
18 years of age. 
Inclusion criteria for subjects in the study group was active treatment with a combined activator-
high-pull headgear appliance as described by Teuscher (1978) of at least 9 months between 9 and 14 
years of age. The study group consisted of 32 subjects, 16 males and 16 females. Mean ages, skeletal 
and airway measurements are given in Table 1. According to the principals of the clinic, only a 
moderate construction bite (typically 3-4mm) was taken, resulting in some cases in a two-step 
activation and care was taken to avoid increasing the vertical dimension during treatment. Therefore, 
a short phase with a fixed appliance was performed on 12 of the 32 patients prior to the combined 
activator-headgear treatment, mainly to allow an unhindered forward positioning of the lower jaw. 
The activator was equipped with torque-control auxiliaries for the upper incisors, and the edges of 
the lower incisors were embedded in acrylic. The face-bow was mounted directly on the activator 
and the direction of the extraoral force was posterior cranial. The mean treatment time with the 
activator-high-pull headgear appliance was 17±6.5 months (range 9-32 months), followed by fixed 
orthodontic treatment in 27 patients. Final treatment outcome, such as achievement of Class I was 
not an inclusion or exclusion criteria. 
For ethical reasons, no untreated control group was available. Therefore, individuals were chosen 
who had only minor treatment carried out between 9 and 16 years of age. In most cases the 
treatment was undertaken for aesthetic reasons only and involved partial or full fixed orthodontic 
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treatment. No Class II mechanics such as headgear, activator or Class II elastics were allowed. The 
control group consisted of 32 subjects, 16 males and 16 females. The mean ages, skeletal and airway 
measurements are given in Table 1. 
Skeletal differences between the groups were inevitable due to the appliance dictated patient 
selection. Patients in the activator-headgear group who received therapy primarily because of a 
skeletal Class II malocclusion were expected to be initially more Class II than the controls. Since a 
certain overlapping of the groups was desired, no skeletal parameters were defined which would 
result in a larger separation of the groups. Contrary to the sagittal skeletal relationship facial 
divergency was very similar in both groups. 
 
Method 
 
Lateral cephalograms were taken with the Frankfort horizontal plane parallel to the floor. For 
every patient, the three cephalograms (T1, T2, T3) were hand-traced and then scanned at 600dpi 
(Duoscan HiD, AGFA, Mortsel, Belgium). The resulting 192 digitized tracings were calibrated on a 
known length and measured with ImageTool 3.00 for Windows (University of Texas Health Science 
Center, San Antonio, Texas, USA). Correction of the x-ray magnification (7.5%) was also made to 
facilitate comparison with previous published data. The measured angles, distances and areas are 
defined and illustrated in Figure 1. To study somatic growth, body height was measured at the same 
time the lateral cephalograms were taken. Since one or more body height readings were missing in 
eight individuals, only 29 patients and 27 controls could be considered in the analysis involving the 
body height. 
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Error of method 
 
The measurements of the first cephalogram of all 64 patients were repeated (MH) at an interval 
of 6 weeks, and the reproducibility of the measurements (limits of agreement) was assessed using 
the method Bland and Altman (1986; 1999). Furthermore, the first and second readings were 
compared using the concordance correlation coefficient (Lin, 1989). 
 
Statistical method 
 
Statistical analyses were performed using the Statistical Package for Social Sciences 15.01 for 
Windows (SPSS Inc, Chicago, Illinois, USA) and MedCalc 9.3 (MedCalc Software, Mariakerke, 
Belgium). For descriptive analyses, the means, standard deviations (SD) and ranges of the 
measurements at the three time points were computed. Moreover, the differences in measurements 
between the time points were calculated, and descriptive statistics of the longitudinal changes 
(means, SD and ranges) were given. In order to demonstrate differences between the study and 
control group, a two-sample t-test was applied. When Levene's test indicated different variances in 
the groups, the results from the Welch-Test were reported. Mean differences and 95 percent 
confidence intervals (CI) for the differences between groups were computed. Additionally a paired t-
test was carried out to test for significant longitudinal changes within the groups. To analyze the 
degree of association between two continuous variables, Pearson's correlation coefficient, with a 95 
percent confidence interval was used. In order to analyze the relationship between one or more 
predictors and the observed change over time, multiple regression analyses were carried out. A p-
value of less than 0.05 was chosen to assign statistical significance for all tests. Results with a p-value 
above 0.05 and smaller than 0.10 were interpreted as a tendency. 
Results 
 
Lower and upper limit of agreement according to Bland and Altman (1986, 1999) were as follows: 
-7.7mm2, 6.6mm2 for area measurement, -0.53°, 0.56° for angle measurements, -0.46 mm, 0.37mm 
for distance "t"  and -0.63mm, 0.61mm for the longest distance "l". For all measurements Lin's (1989) 
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concordance correlation coefficient was above 0.99, indicating good repeatability of the 
measurements. 
The only variables that significantly differed between the groups at T1 were SNB (2.02°, p=0.017), 
ANB (-2.41°, p<0.001) and the length of the pharynx "l" (2.00mm, p=0.030), with the study group 
showing a smaller pharynx length and SNB angle which consequently lead to a greater ANB angle 
(Table 1). The pharyngeal area and distance "t" also tended to be smaller in the study group. At T2 
and T3 differences between the groups were generally smaller, however, SNB (2.17°, p=0.017) and 
ANB (-1.14°, p=0.029) still remained significantly different. 
The study group had a longer treatment period (T1-T2) and showed more body height growth 
during that time, but neither of these factors reached statistical significance (Table 2). The annual 
growth rate was slightly greater in the control group. To compare the groups longitudinally, 
discrepancies in the growth differences of the groups were measured. During the treatment period 
the study group had a significantly greater reduction of SNA (-1.81°, p<0.001) and ANB (-1.43°, 
p<0.001), while there was no statistically significant effect in the SNB. At the same time the study 
group showed statistically significant increases (compared to the controls) in the following 
pharyngeal parameters: area (129.50 mm2, p=0.007), length (5.69mm, p<0.001) and the smallest 
distance between the tongue and the posterior pharyngeal wall "t" (1.51mm, p=0.038). The changes 
in these parameters were also longitudinally significant in the study group. From T2 to T3 there were 
no statistically significant differences between the groups; instead, both groups underwent 
essentially the same changes, implying no reduction but rather a minor increase in the established 
changes during this period. 
Using multiple linear regressions, the relationship between the observed changes in the 
pharyngeal area and distance "t" as the dependent variables and several predictor variables, was 
determined (Table 3). For the area change during T1 to T2 the only significant predictor variable was 
the inclusion to the study or the control group; for the distance "t" a similar tendency was found. 
During T2 to T3 group association (patient versus control) was no longer of relevance and the only 
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significant predictor variable was body height growth. For the distance "t", a tendency could also be 
found when the change in SNB was taken into account as a predictor factor. 
Considering only the changes in the control group, normal growth of the pharyngeal airway during 
T1 to T3 can be studied. The length (10.44mm, p<0.001), distance "p" (1.41mm, p<0.001) and the 
area (130.26 mm2, p=0.003) demonstrated a significant increase from T1 to T3, while distances "w" 
and "t" had no significant increase and showed only minimal enlargement. During this period ANB (-
1.33°, p<0.001) and SN/ML (-1.87°, p<0.001) showed a significant angle reduction and were positively 
associated with each other (r= 0.53, p=0.002). Again taking only the control group into account, 
Pearson's correlation coefficient revealed that body height growth had a significant positive 
association with the change in pharyngeal length (r= 0.61, p<0.001), the change in area [r= 0.41, 
p=0.032) and a negative association with the change in ANB angle (r= -0.43, p=0.027). However, an 
expected correlation between the change in the pharyngeal area and that in SNB (r=0.20, p=0.262) or 
the change in SN/ML (r= -0.22, p=0.22) was only weak. 
Comparing the changes between genders longitudinally, there were no significant differences in 
the skeletal or airway parameters in either group during the period T1-T2. For T2 to T3 however, 
males showed a significantly greater body height growth, pharyngeal length and a tendency for an 
increase in SNB in both groups. At the long-term follow-up, the absolute values for females were 
similar to those of the males. Equal distribution of genders in the groups allowed pooling of data for 
males and females. 
Discussion 
 
It is evident that measurements on a two-dimensional cephalometric radiograph cannot reveal 
the transverse dimension of the airway. For this reason, three-dimensional imaging such as cone 
beam technology would be the preferred method. Since this technology was only introduced in 
recent years and has until now a relatively high radiation dose for regular treatment monitoring, no 
long-term data will be available for some time. Therefore, the conventional lateral cephalogram 
remains a valuable and reliable diagnostic tool which has been used in numerous airway studies. 
11 
The longitudinal changes in the control group in this study revealed that not all pharyngeal 
dimensions increase during adolescence. While the length of the pharynx "l" steadily increased, the 
smallest distance between the tongue base and the posterior pharyngeal wall "t" did not significantly 
increase. The present findings for distance "t" are in agreement with an earlier study (McNamara, 
1984), who found no appreciable changes with age and showed the average value of this 
measurement to be between 10 and 12mm (9-11mm without magnification). The present results for 
the pharyngeal length are also consistent with other findings later in life, between 20 and 50 years of 
age, which show continued vertical growth in pharyngeal length and a reduction in pharyngeal depth 
(Johnston and Richardson, 1999). Growth differences in pharyngeal dimensions between males and 
females were generally small, and at T3 both genders had reached similar absolute values, which is in 
line with a previous study (Abu Allhaija and Al-Khateeb, 2005). 
At T1, the study group, which was, on average, skeletally more Class II than the controls, showed 
a tendency for a smaller pharyngeal area and distance between the tongue base and the posterior 
pharyngeal wall "t". These findings agree with other studies that showed a weak but significant 
correlation between the skeletal configuration (ANB) and inferior pharyngeal airway space (Ceylan 
and Oktay, 1995; Abu Allhaija and Al-Khateeb, 2005). Clinical relevance was established by a study on 
121 patients demonstrating an increasing severity of OSA with increasing overjet (Bates and 
McDonald, 2005), measured on lateral cephalograms. 
During T1 to T2, the study group showed significantly greater increases compared with the 
controls in the distance "t", the pharyngeal length and the pharyngeal area. During T2 to T3 these 
established changes remained and the groups showed similar growth. Taking into account the norm 
for the distance "t", which is 10-12mm (McNamara, 1984), it becomes clear that the activator-
headgear group was initially below the average and could reach normal values during treatment in a 
airway-measurement that normally does not demonstrate any significant growth. This is illustrated in 
Figures 2 and 3, where the study group, which started with lower values, surpassed controls during 
treatment and showed no decrease in the changes during the follow up period. The body height 
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measurements helped to verify that both groups had similar growth rates and that there was no 
biased selection of patients and controls. 
Even though determing skeletal changes was not the primary goal of this study, it is evident that 
the combined activator-high-pull headgear appliance had a great impact on the maxilla. While SNA 
remained constant in the controls, there was a reduction in the study group. However, this did not 
reduce the smallest distance between the soft palate and the posterior pharyngeal wall "p". In 
another study (Kirjavainen and Kirjavainen, 2007), retropalatal airway space was even increased 
during cervical headgear treatment in Class II children, whereas the oro- and hypopharynx remained 
unchanged. SNB demonstrated similar increases in both groups and the potential effect of the 
activator-headgear appliance on lower jaw growth could not be verified from the present data. 
Nevertheless, since the study group had a more retrognathic mandible at T1, perhaps resulting in 
diminished future lower jaw growth if left untreated (Lux et al., 2005; Franchi et al., 2007), the 
similar growth rate alone could be a positive effect of the appliance. To support this hypotheses an 
untreated Class II group would be needed. 
The positive impact of activator-headgear therapy on the airway dimensions cannot be explained 
just by the established skeletal changes. The present data suggests that the underlying mechanism is 
more complex, also having an effect on the soft tissues. Different posture of the tongue caused by 
increased genioglossal muscle tonus or other soft tissues changes may play an important role and are 
probably induced by forward positioning of the mandible during activator-headgear treatment. This 
effect seems to be similar to the way mandibular advancement devices (MAD) work in adults. A 
study on the effect of MAD's in subjects with OSA showed that the minimal distance behind the 
tongue improves by 0.8mm while wearing these devices (Battagel et al., 1999). In the present study 
the minimal distance behind the tongue "t" improved by 2.5mm on average in the activator-
headgear group during the observation period. Even though this seems to be a small increase, it is 
nevertheless clinically significant, considering that a 0.8mm increase with MAD's has a positive effect 
on OSA. 
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Another possible explanation for the improvement in the activator-headgear group could be a 
"catch-up growth" concept, where children with small oropharyngeal dimensions would have a 
greater intrinsic stimulus to increase their capacity for respiratory function (Ozbek et al., 1998). 
Nonetheless, it is noteworthy that individual differences in normal growth and in the response to 
treatment are considerable. However, even a small diameter change can result in a substantial 
volumetric change and can have a great effect on airflow because the resistance decreases to the 
fourth power as the radius increases. 
OSA children with large adenoids and tonsils have been found to have somatic growth 
impairment due to abnormal nocturnal growth hormone (GH) secretion. After adenotonsillectomy, 
which is the first treatment of choice in OSA children, a significant increase in serum levels of GH 
mediators and a normalization of somatic growth can be observed (Bar et al., 1999; Nieminen et al., 
2002). Most likely, the explanation for this improvement is the demonstrated link between 
insufficient sleep patterns or stages and nocturnal release of GH (Spath-Schwalbe et al., 1995; 
Steiger, 2002). The same occurrence seems also plausible in OSA children that have severe 
mandibular retrognathism as their primary cause of airway obstruction. In these children, activator-
headgear therapy could also stimulate GH secretion by normalization of nocturnal breathing and 
thereby have a positive effect on mandibular growth. It has been demonstrated that GH increases 
endochondral bone formation in the condylar cartilage and enhances ramus height by augmented 
bone apposition in the lower border of the mandible (through anabolic effects of GH on masticatory 
muscles) (Vogl et al., 1993). Of course, such a positive sequence achieved by activator-headgear 
treatment, is currently hypothetical and must be confirmed in a further study. 
Snoring and OSA are described as two aspects of the same basic disorder, namely sleep-related 
narrowing of the upper airways which differ only in severity (Lugaresi and Plazzi, 1997). The patency 
of the upper airway depends on the balance between the negative intrapharyngeal pressure 
developed during inspiration and its counteraction by dilating muscles (Friberg, 1999). It is clear that 
upper airway collapse most often results from a combination of anatomic factors that predispose the 
airway to collapse during inspiration, plus neuromuscular compensation that is insufficient during 
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sleep to maintain airway patency (Young et al., 2002). Therefore, it is possible that small pharyngeal 
dimensions established early in life may predispose to OSA and snoring later when subsequent soft 
tissue changes (Martin et al., 1997) (caused by age, obesity or genetic background) further reduce 
the available oropharyngeal airway. Consequently, it can only be regarded as beneficial if functional-
orthopedic treatment in children (Ozbek et al., 1998) or surgical mandibular advancement (Achilleos 
et al., 2000) results in a permanent increase in pharyngeal airway dimensions. 
Conclusions 
 
The present findings indicate that activator-headgear therapy (followed by fixed appliance 
treatment) has the potential to increase pharyngeal airway dimensions, such as the smallest distance 
between the tongue base and the posterior pharyngeal wall or the pharyngeal area. Importantly, this 
achieved increase seems to be maintained in the long-term, up to 22 years on average according to 
the findings of the present research. However, it is noteworthy that, as in all orthodontic studies 
involving growing children, individual differences in normal growth and in the response to treatment 
were substantial. The evident increase in the airway dimension obtained by functional orthopaedic 
treatment may reduce the risk of developing OSA in later life. This treatment can therefore be 
considered not only beneficial from the dental point of view but also from a general medical 
perspective. 
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Figure captions 
 
Figure 1 
 
The cephalometric measurements used in this study to determine skeletal changes were SNA, 
SNB, ANB and SN/ML (Mandibular Line: Menton-Gonion) angels. Pharyngeal airway was assessed 
with the following measurements: "l": pharyngeal length, the longitudinal axis of the pharynx starting 
at the most cranial point of the pharynx and ending at a line parallel to Frankfurt horizontal through 
the most anterior inferior point of the fourth vertebral corpus, "p": the smallest distance between 
the soft palate and the posterior pharyngeal wall, "w": the largest distance perpendicular to the 
longitudinal axis of the pharynx, between the lines p and t, "t": the smallest distance between the 
tongue base and the posterior pharyngeal wall, "area" (marked grey): the area between line "p" and 
the line parallel to FH through the most anterior inferior point of C4. When a gap was present 
between the tongue and the soft palate, this area was not considered. The area above line "p" was 
intentionally not included due to the possibly falsifying influence of the adenoids in growing children. 
Figure 2 
 
Longitudinal development of the smallest distance between the tongue base and the posterior 
pharyngeal wall "t" at the different time points. The growth rate was significantly different between 
the groups during the treatment phase (T1-T2), but not during the follow-up period (T2-T3). 
Figure 3 
 
Longitudinal development of the pharyngeal area defined in Figure 1 at the different time points. 
The growth rate was significantly different between the groups during the treatment phase (T1-T2), 
but not during the follow-up period (T2-T3). 
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Table 1  Means, standard deviations and p-values of two-sample t-test comparing the activator-headgear group 
and the controls at the three time points. 
  T1 (pretreatment) T2 (end of treatment) T3 (end of recall) 
  n study group controls p-value study group controls p-value study group controls p-value 
age (years) 64 10.2 ±1.1 10.7 ±1.6 0.164 14.6 ±1.2 14.4 ±1.4 0.569 22.2 ±2.7 21.9 ±2.3 0.590 
body height (cm) 56 140.3 ±6.5 140.9 ±9.9 0.800 164.0 ±7.1 163.0 ±8.3 0.630 172.2 ±8.6 171.9 ±8.2 0.882 
SNA (°) 64 81.9 ±3.8 81.5 ±4.0 0.686 80.4 ±3.8 81.8 ±4.0 0.157 80.8 ±3.3 81.9 ±3.9 0.258 
SNB (°) 64 76.3 ±3.2 78.3 ±3.4 0.017* 76.8 ±3.6 79.2 ±3.6 0.010* 77.8 ±3.3 80.0 ±3.8 0.017* 
ANB (°) 64 5.6 ±2.0 3.2 ±2.0 0.001* 3.6 ±1.7 2.6 ±1.8 0.029* 3.0 ±2.1 1.9 ±2.0 0.029* 
SN/ML (°) 64 33.7 ±4.7 33.2 ±5.0 0.742 33.0 ±5.8 32.5 ±5.3 0.700 30.7 ±6.6 31.4 ±5.9 0.688 
p (mm) 64 8.3 ±2.4 7.9 ±2.4 0.519 9.0 ±2.3 8.3 ±2.7 0.283 9.6 ±2.5 9.3 ±2.5 0.648 
w (mm) 64 12.6 ±3.0 12.6 ±3.3 0.922 12.9 ±2.7 12.9 ±4.1 0.942 14.1 ±3.3 13.7 ±3.5 0.650 
t (mm) 64 8.5 ±2.6 10.0 ±3.7 0.073 9.8 ±2.9 9.8 ±3.6 0.939 11.1 ±3.4 10.4 ±2.9 0.432 
length (mm) 64 76.5 ±6.6 81.0 ±9.2 0.030* 87.7 ±7.6 86.4 ±8.7 0.549 92.5 ±8.6 91.4 ±8.5 0.619 
area (mm2) 64 445.5 ±151.7 540.0 ±231.6 0.058 608.7 ±195.3 573.7 ±215.4 0.499 724.2 ±229.2 670.3 ±196.7 0.317 
 
* P < 0.05 
Table 2   Longitudinal mean changes, standard deviations and p-values for the activator-headgear group and the 
controls. Two-sample t-test was used for intergroup comparison and paired t-test for longitudinal 
changes within the group. 
  T1-T2 (treatment) T2-T3 (post-treatment) T1-T3 (over all) 
  n study group controls P-value study group controls P-value study group controls P-value 
years 64 4.4 ±1.2 3.8 ±1.6 0.064 7.6 ±2.5 7.4 ±2.3 0.795 12.0 ±2.9 11.2 ±2.6 0.235 
∆ body height (cm) 56 23.7 ±5.2# 22.1 ±7.4# 0.362 8.2 ±7.8# 8.9 ±7.6# 0.749 31.9 ±8.7# 31.0 ±9.7# 0.712 
∆ SNA (°) 64 -1.5 ±1.8# 0.3 ±1.8 0.001* 0.5 ±1.3# 0.1 ±0.9 0.166 -1.1 ±1.8# 0.3 ±1.7 0.002*
∆ SNB (°) 64 0.5 ±1.5 0.9 ±1.6# 0.334 1.0 ±1.6# 0.8 ±1.2# 0.518 1.5 ±2.1# 1.7 ±1.9# 0.764 
∆ ANB (°) 64 -2.1 ±1.5# -0.6 ±1.3# 0.001* -0.5 ±1.0# -0.7 ±1.2# 0.580 -2.6 ±1.8# -1.3 ±1.6# 0.005*
∆ SN/ML (°) 64 -0.7 ±2.3 -0.8 ±1.6# 0.789 -2.2 ±2.5# -1.1 ±2.3# 0.059 -2.9 ±3.3# -1.9 ±2.9# 0.186 
∆ p (mm) 64 0.7 ±2.8 0.4 ±1.9 0.628 0.6 ±1.6# 1.0 ±1.7# 0.328 1.3 ±3.1# 1.4 ±2.1# 0.877 
∆ w (mm) 64 0.3 ±3.1 0.3 ±3.0 0.984 1.2 ±2.6# 0.8 ±3.0 0.520 1.5 ±4.1# 1.1 ±3.0 0.604 
∆ t (mm) 64 1.3 ±3.0# -0.2 ±2.7 0.038* 1.2 ±3.1# 0.7 ±2.8 0.448 2.5 ±3.5# 0.5 ±3.4 0.020*
∆ length (mm) 64 11.1 ±6.4# 5.4 ±6.8# 0.001* 4.8 ±6.6# 5.0 ±6.8# 0.925 16.0 ±7.6# 10.4 ±8.1# 0.006*
∆ area (mm2) 64 163.2 ±198.9# 33.7 ±175.0 0.007* 115.5 ±192.6# 96.6 ±190.3# 0.693 278.7 ±241.0# 130.3 ±231.9# 0.015*
 
* P < 0.05 (significant differences between the groups), # P < 0.05 (significant longitudinal changes within the group) 
Table 3   Multiple linear regressions on 56 observations for longitudinal changes in distance "t" and area during 
T1-T2 and T2-T3. Explanatory variables were: group (study or control), gender, body height growth, SNB 
and SN/ML change. 
  ∆ distance "t" ∆ area 
    T1-T2 (r2 adj.=0.01) T2-T3 (r2 adj.=0.12) T1-T2 (r2 adj.=0.09) T2-T3 (r2 adj.=0.29) 
  coefficient std. error P-value coefficient std. error P-value coefficient std. error P-value coefficient std. error P-value 
group (stu=1, con=0) 1.47 0.82 0.079 0.39 0.74 0.595 111.71 52.03 0.036* -9.99 43.29 0.818 
gender (m=0, f=1) -0.35 0.82 0.668 0.97 0.90 0.283 2.46 51.55 0.962 43.99 52.58 0.407 
∆ body height 0.01 0.07 0.774 0.17 0.07 0.016* 5.65 4.11 0.176 15.19 3.88 0.001*
∆ SNB -0.19 0.34 0.582 0.59 0.35 0.097 -22.16 21.59 0.310 14.23 20.30 0.487 
∆ SN/ML 0.11 0.26 0.674 0.24 0.21 0.247 -1.29 16.60 0.938 4.17 12.51 0.741 
 
* P < 0.05 
